211 related articles for article (PubMed ID: 34318601)
1. A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.
Ruscitti F; Trevisan L; Rosti G; Gotta F; Cianflone A; Geroldi A; Origone P; Pichiecchio A; Viglio S; Iascone M; Mandich P
Mol Genet Genomic Med; 2021 Sep; 9(9):e1753. PubMed ID: 34318601
[TBL] [Abstract][Full Text] [Related]
2. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
[TBL] [Abstract][Full Text] [Related]
3. A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome.
Olson SL; Murray ML; Skeik N
Ann Vasc Surg; 2019 Nov; 61():472.e9-472.e13. PubMed ID: 31394236
[TBL] [Abstract][Full Text] [Related]
4. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
[TBL] [Abstract][Full Text] [Related]
5. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
[TBL] [Abstract][Full Text] [Related]
7. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.
Shalhub S; Neptune E; Sanchez DE; Dua A; Arellano N; McDonnell NB; Milewicz DM
Am J Med Genet A; 2019 May; 179(5):797-802. PubMed ID: 30793832
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
[TBL] [Abstract][Full Text] [Related]
11. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
[TBL] [Abstract][Full Text] [Related]
12. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
[TBL] [Abstract][Full Text] [Related]
15. A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.
Cortini F; Marinelli B; Romi S; Seresini A; Pesatori AC; Seia M; Montano N; Bassotti A
Vasc Endovascular Surg; 2017 Apr; 51(3):141-145. PubMed ID: 28183226
[TBL] [Abstract][Full Text] [Related]
16. Two closely spaced missense COL3A1 variants in cis cause vascular Ehlers-Danlos syndrome in one large Chinese family.
Liang M; Chen C; Dai Y; Chang Y; Gao Y
J Cell Mol Med; 2022 Jan; 26(1):144-150. PubMed ID: 34845833
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pneumothorax and intrapulmonary cavitary lesions in a male patient with vascular Ehlers-Danlos syndrome and a novel missense mutation in the COL3A1 gene: a case report.
Wan T; Ye J; Wu P; Cheng M; Jiang B; Wang H; Li J; Ma J; Wang L; Huang X
BMC Pulm Med; 2020 May; 20(1):149. PubMed ID: 32471395
[TBL] [Abstract][Full Text] [Related]
19. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
[TBL] [Abstract][Full Text] [Related]
20. Identification of two novel COL3A1 variants in patients with vascular Ehlers-Danlos syndrome.
Heo WY; Jang SY; Park TK; Ki CS; Kim JW; Kim DK; Jang JH
Mol Genet Genomic Med; 2023 Sep; 11(9):e2240. PubMed ID: 37461200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]